Rite Aid (RTA1) Stock Overview
Through its subsidiaries, operates a chain of retail drugstores in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
RTA1 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Rite Aid Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.20 |
| 52 Week High | US$2.80 |
| 52 Week Low | US$0.13 |
| Beta | 1.32 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -88.17% |
| 3 Year Change | -98.61% |
| 5 Year Change | -97.39% |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| RTA1 | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | -2.3% |
| 1Y | -88.2% | -11.7% | 4.8% |
Return vs Industry: RTA1 underperformed the German Consumer Retailing industry which returned -37.2% over the past year.
Return vs Market: RTA1 underperformed the German Market which returned 2% over the past year.
Price Volatility
| RTA1 volatility | |
|---|---|
| RTA1 Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 5.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: RTA1's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine RTA1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 47,000 | Jeffrey Stein | www.riteaid.com |
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line.
Rite Aid Corporation Fundamentals Summary
| RTA1 fundamental statistics | |
|---|---|
| Market cap | €7.66m |
| Earnings (TTM) | -€1.52b |
| Revenue (TTM) | €21.81b |
Is RTA1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RTA1 income statement (TTM) | |
|---|---|
| Revenue | US$23.48b |
| Cost of Revenue | US$18.75b |
| Gross Profit | US$4.73b |
| Other Expenses | US$6.36b |
| Earnings | -US$1.64b |
Last Reported Earnings
Sep 02, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -29.75 |
| Gross Margin | 20.14% |
| Net Profit Margin | -6.97% |
| Debt/Equity Ratio | -191.6% |
How did RTA1 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/05 18:31 |
| End of Day Share Price | 2024/02/06 00:00 |
| Earnings | 2023/09/02 |
| Annual Earnings | 2023/03/04 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Rite Aid Corporation is covered by 16 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Valiquette | BofA Global Research |
| William Frohnhoefer | BTIG |
| George Hill | Deutsche Bank |